Fred E Cohen
CIK 1339358 · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$47.90M
Companies
12
Total Filings
163
Lifetime Open-Market Net
-$3.60M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NTLA | Director | 216,653 | $12.11 | $2.62M | $1.40M | 12 | 2026-06-10 |
| KYTX | Director | 4,545,651 | $8.05 | $36.62M | $0 | 3 | 2026-05-29 |
| CDNA | Director | 155,265 | $22.97 | $3.57M | $0 | 33 | 2025-06-17 |
| URGN | Director | 84,339 | $29.72 | $2.51M | $0 | 8 | 2024-08-08 |
| PGNY | Director | 22,693 | $26.63 | $604.3K | $0 | 6 | 2024-05-28 |
| VCYT | Director | 10,000 | $47.33 | $473.3K | -$1.07M | 9 | 2020-10-20 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 75,188 | — | — | -$3.63M | 57 | 2019-10-03 |
| TNDM | Director | — | $16.60 | — | $0 | 7 | 2018-11-19 |
| BCRX | Director | 173,660 | $8.70 | $1.51M | -$294.0K | 19 | 2018-06-22 |
| Roka BioScience, Inc. (ROKA) Delisted | Director | — | — | — | $0 | 3 | 2017-06-30 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | — | $178.75 | — | $0 | 2 | 2017-05-12 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Director | 24,807 | $38.00 | $942.7K | $0 | 3 | 2016-01-13 |
Recent Filings · Page 2 of 17
163 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-28 | PGNY | Grant (A) | +6,176 | $0 | EDGAR |
| 2024-02-14 | KYTX | Conv (C) | +4,523,924 | $0 | EDGAR |
| 2023-09-08 | URGN | Grant (A) | — | $0 | EDGAR |
| 2023-07-28 | URGN | Grant (A) | +69,339 | $661.5K | EDGAR |
| 2023-06-21 | CDNA | Grant (A) | +18,844 | $0 | EDGAR |
| 2023-06-16 | NTLA | Grant (A) | +4,425 | $0 | EDGAR |
| 2023-05-26 | PGNY | Grant (A) | +4,385 | $0 | EDGAR |
| 2023-01-09 | CDNA | Grant (A) | +1,062 | $0 | EDGAR |
| 2022-10-26 | PGNY | Grant (A) | +3,480 | $0 | EDGAR |
| 2022-10-04 | CDNA | Grant (A) | +803 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.